Therapeutic drug monitoring for IBD
Project/Area Number |
15K08967
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | Shiga University of Medical Science |
Principal Investigator |
Andoh Akira 滋賀医科大学, 医学部, 教授 (90252395)
|
Project Period (FY) |
2015-04-01 – 2018-03-31
|
Project Status |
Completed (Fiscal Year 2017)
|
Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | IBD / 抗TNF抗体 / 炎症性腸疾患 / 抗サイトカイン療法 / IgG / アダリムマブ |
Outline of Final Research Achievements |
he present report describes a new ELISA system for measurement of serum ADA concentrations. In this system, non-specific binding of serum IgG was markedly blocked and did not require specific materials, such as anti-ADA idiotype antibodies. In addition, this study describes a novel immunoassay for AAAs that can measure AAAs in the presence of free ADA. These methods improved the diagnostic accuracy for measurement of serum ADA and AAA concentrations and might be useful for determination of the therapeutic approach for patients with a loss of response to ADA.
|
Report
(4 results)
Research Products
(5 results)
-
-
-
-
-
[Journal Article] Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease.2016
Author(s)
Nishida A, Hidaka K, Kanda T, Imaeda H, Shioya M, Inatomi O, Bamba S, Kitoh K, Sugimoto M, Andoh A.
-
Journal Title
Inflammatory bowel disease
Volume: 22
Issue: 2
Pages: 303-314
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant